Increasing dosage of clopidogrel for patients with genetic variation improves response to medication

Among patients with stable cardiovascular disease who have a genetic variation that diminishes the response to the antiplatelet drug clopidogrel, tripling the standard daily dosage of this medication resulted in improved platelet reactivity, according to a new study.

Read the whole article on Science Daily

More from Science Daily